Haemonetics (HAE) Share-based Compensation Growth (1y) (2010 - 2026)
Haemonetics (HAE) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | 100.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 100.37% |
| Dec 27, 2025 | -98.05% |
| Sep 27, 2025 | -195.40% |
| Jun 28, 2025 | -4.49% |
| Dec 28, 2024 | 19,002.33% |
| Sep 28, 2024 | 512.82% |
| Jun 29, 2024 | 39.50% |
| Dec 30, 2023 | -99.43% |
| Sep 30, 2023 | -110.40% |
| Apr 1, 2023 | 3.83% |
| Dec 31, 2022 | 16.05% |
| Oct 1, 2022 | 84.55% |
| Apr 2, 2022 | -370.91% |
| Jan 1, 2022 | 2.67% |
| Oct 2, 2021 | 0.45% |
| Jul 3, 2021 | 10.72% |
| Apr 3, 2021 | 31.69% |
| Dec 26, 2020 | 18.07% |
| Sep 26, 2020 | 19.04% |
| Jun 27, 2020 | 30.38% |